BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
143 hedge funds and large institutions have $210M invested in BioDelivery Sciences International, Inc. in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 50 reducing their positions, and 21 closing their positions.
247% more call options, than puts
Call options by funds: $4.2M | Put options by funds: $1.21M
6% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 50
5% less funds holding
Funds holding: 151 → 143 (-8)
16% less capital invested
Capital invested by funds: $251M → $210M (-$40.8M)
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.88M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$1.58M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.08M |
| 4 |
RA
Royce & Associates
New York
|
+$1.06M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$849K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$7.82M |
| 2 |
BlackRock
New York
|
-$4.04M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$3.58M |
| 4 |
Goldman Sachs
New York
|
-$2.94M |
| 5 |
Two Sigma Investments
New York
|
-$1.66M |
BDSI Hedge Fund Activity: Q2 2021 in Review
143 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2021, worth a combined $210M — down 16% from $251M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of BDSI and 13 opened new positions — a net loss of 8 holders — while 50 trimmed existing stakes and 47 added.
The largest buyer was JP Morgan Chase, adding an estimated $1.88M. The largest seller was HealthInvest Partners, exiting entirely with an estimated $7.82M sold.
- 143 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2021, down from 151 in Q1 2021.
- Funds reported $210M of BioDelivery Sciences International, Inc. stock for Q2 2021, down 16% quarter-over-quarter.
- 13 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2021 and 21 closed out, a net change of -8 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q2 2021 was JP Morgan Chase, an estimated $1.88M added.
- The largest BioDelivery Sciences International, Inc. seller in Q2 2021 was HealthInvest Partners, an estimated $7.82M sold.
Based on aggregated 13F filings for Q2 2021.